PERBANDINGAN PENGARUH AIR REBUSAN DAUN SALAM (SYZYGIUM POLYANTHUM) DAN DAUN KELOR (MORINGA OLEIFERA) TERHADAP KADAR GULA DARAH PASIEN DIABETES MELITUS TIPE 2
COMPARISON THE EFFECTS OF BAY LEAF (SYZYGIUM POLYANTHUM) AND MORINGA LEAF (MORINGA OLEIFERA) ON BLOOD GLUCOSE LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
DOI:
https://doi.org/10.51898/wb.v10i2.348Keywords:
Bay leaf, Moringa leaf, Type 2 Diabetes Mellitus, Blood glucose levelAbstract
Type 2 diabetes mellitus is a progressive metabolic condition associated with insulin resistance and hyperglycemia. Achieving adequate glycemic control remains a key strategy in reducing the risk of diabetic complications. This research investigated the effectiveness of bay leaf (Syzygium polyanthum) and moringa leaf (Moringa oleifera) decoctions as complementary approaches to manage blood glucose levels among type 2 diabetes patients in Manunggal Village, under the supervision of UPTD Puskesmas Batulicin I. The study adopted a quasi-experimental design employing a two-group pretest–posttest method. A total of 20 female respondents aged 41–60 years were purposively selected and evenly allocated to two intervention groups: bay leaf decoction and moringa leaf decoction. Participants consumed 200 ml of decoction twice daily for seven days. The findings revealed that while bay leaf decoction reduced blood glucose to a moderate category (mean post-test 208.6 mg/dL), moringa leaf decoction produced a significantly greater effect, with a mean post-test of 165.3 mg/dL (p = 0.000, <0.05). Notably, 90% of the moringa group achieved normal glucose levels after the intervention. In conclusion, moringa leaf decoction demonstrated superior efficacy compared with bay leaf decoction and can be considered as a supportive therapy to complement standard diabetes treatment for optimal glycemic control.References
Admar, M. A., & Mayasari, D. (2024). Case report: Management of a patient with type 2 diabetes mellitus and uncontrolled hypertensive urgency using a family doctor approach in a first-level health facility in Indonesia. International Journal of Current Science Research and Review, 7(12), 9153–9158. https://ijcsrr.org/wp-content/uploads/2024/12/61-2512-2024.pdf
American Diabetes Association Professional Practice Committee. (2024). 2. Diagnosis and classification of diabetes: Standards of care in diabetes—2024. Diabetes Care, 47(Suppl 1), S20–S42. https://doi.org/10.2337/dc24-S002
Cantona, M. A. E. (2022). Pengaruh air rebusan daun kelor terhadap penurunan kadar gula darah pada penderita diabetes melitus di Desa Balerejo Kecamatan Balerejo Kabupaten Madiun. STIKES Bhakti Husada Mulia.
Dwijayanti, R., & Astriani, N. (2019). The effect of bay leaf (Syzygium polyanthum) decoction on blood glucose levels in type 2 diabetes mellitus patients. Journal of Herbal Medicine in Clinical Practice, 5(1), 14–20.
IDF. (2021). International diabetes atlas (10th ed.). Diabetes Research and Clinical Practice, 10(2).
Kementerian Kesehatan Republik Indonesia. (2023). Laporan nasional riset kesehatan dasar (Riskesdas) 2023. Jakarta: Badan Penelitian dan Pengembangan Kesehatan, Kemenkes RI. https://www.litbang.kemkes.go.id
Kementerian Kesehatan Republik Indonesia. (2023). Keputusan Direktur Jenderal Pelayanan Kesehatan Nomor HK.02.02/I/105/2023 tentang instrumen survei akreditasi klinik. Jakarta: Kemenkes RI.
Mulyanto, T., & Saifudin, R. (2025). Hubungan pola makan dan aktivitas fisik dengan kejadian diabetes melitus di Balai Besar Kekarantinaan Kesehatan Tanjung Priok. MAHESA: Malahayati Health Student Journal, 5(3), 122–130. https://www.ejurnalmalahayati.ac.id/index.php/MAHESA/article/view/19466
Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., Cavan, D., Shaw, J. E., & Makaroff, L. E. (2022). IDF diabetes atlas: Global estimates of diabetes prevalence for 2021 and projections for 2045. Diabetes Research and Clinical Practice, 183, 109119. https://doi.org/10.1016/j.diabres.2021.109119
Prameswari, R., & Widjanarko, S. B. (2018). The effect of bay leaf (Syzygium polyanthum) extract on blood glucose levels and insulin resistance in diabetic rats. Journal of Nutrition and Food Research, 41(2), 95–104.
Purba, E. C. (2020). Kelor (Moringa oleifera Lam.): Pemanfaatan dan bioaktivitas. Pro-Life, 7(1). https://doi.org/10.33541/jpvol6iss2pp102
Retnaninggalih Putri, A., Erfan, E., & Hairrudin. (2020). Perbandingan efek air rebusan daun salam dan daun seledri terhadap penurunan kadar LDL darah tikus Wistar model dislipidemia: The comparison of bay leaf and celery leaf infusion effect on decreasing LDL level in dyslipidemic Wistar rats model. Journal of Agromedicine and Medical Sciences, 1(1), 21–24.
Riskesdas. (2018). Laporan Riskesdas 2018 nasional. Jakarta: Badan Penelitian dan Pengembangan Kesehatan, Kemenkes RI.
Rokhmah, D., Rahmawati, D., & Arumsari, N. (2022). Phytochemical content and antidiabetic potential of Moringa oleifera. Asian Journal of Complementary and Alternative Medicine, 10(1), 23–31.
Safitri, A., Widyaningrum, N., & Putri, I. (2023). The effect of Moringa oleifera leaves on blood glucose levels: A systematic review. Journal of Nutraceuticals and Herbal Medicine, 6(2), 45–54.
Setiyaningrum, A., Solikhah, S., & Sulistyawati, S. (2025). Trend and spatial analysis of diabetes mellitus disease 2019–2023 in Yogyakarta City. Kesmas Indonesia, 17(1), 45–56. https://jos.unsoed.ac.id/index.php/kesmasindo/article/download/12936/6252
Setya, M., & Fitriyani, N. (2022). Asuhan keperawatan pasien diabetes mellitus tipe 2 dalam pemenuhan istirahat tidur. Universitas Kusuma Husada Surakarta.
SKI. (2023). Dalam angka. Indo Dalam Angka, 1–68.
World Health Organization. (2023). Global diabetes report 2023. Geneva: WHO. https://www.who.int/publications/i/item/9789240071366
World Health Organization. (2023). 1 in 10 people worldwide living with diabetes. https://www.who.int/news
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Agung Budi Prayoga, Herdy Juniawan, Novia Susanti

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.












